# Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC

> **NCT07239674** · PHASE3 · NOT_YET_RECRUITING · sponsor: **West China Hospital** · enrollment: 646 (estimated)

## Conditions studied

- Intermediate-to-High Risk Differentiated Thyroid Cancer

## Interventions

- **DRUG:** desiccated thyroid extract (DTE)+levothyroxine (L-T4)

## Key facts

- **NCT ID:** NCT07239674
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-11-30
- **Primary completion:** 2027-11-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 646 (ESTIMATED)
- **Last updated:** 2025-11-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07239674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07239674, "Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07239674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*